Report Detail

Request for Sample of this report

Other Global In Vitro Assays to Diagnose Infectious Diseases Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4536380
    • |
  • 14 June, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global In Vitro Assays to Diagnose Infectious Diseases market size was valued at USD 3644.1 million in 2022 and is forecast to a readjusted size of USD 3320.3 million by 2029 with a CAGR of -1.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is a highly sensitive and specific assay that detects the presence of antigens or antibodies in patient samples. ELISA can be used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and Lyme disease.
In Vitro Assays to Diagnose Infectious Diseases market refers to the use of diagnostic tests and devices to detect and diagnose infectious diseases in biological samples such as blood, urine, and other bodily fluids. These tests are performed in vitro, meaning outside of the body in a laboratory setting. The IVD market for infectious diseases includes a range of tests such as immunoassays, molecular diagnostics, and microbiology culture tests, among others. These tests aid in the identification of infectious agents such as bacteria, viruses, fungi, and parasites, and help in the management and treatment of infectious diseases.
This report is a detailed and comprehensive analysis for global In Vitro Assays to Diagnose Infectious Diseases market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global In Vitro Assays to Diagnose Infectious Diseases market size and forecasts, in consumption value ($ Million), 2018-2029
Global In Vitro Assays to Diagnose Infectious Diseases market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global In Vitro Assays to Diagnose Infectious Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global In Vitro Assays to Diagnose Infectious Diseases market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for In Vitro Assays to Diagnose Infectious Diseases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global In Vitro Assays to Diagnose Infectious Diseases market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QIAGEN, BD, bioMerieux SA, F. Hoffmann-La Roche, Ltd. and Hologic, Inc. (Gen-Probe), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
In Vitro Assays to Diagnose Infectious Diseases market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immunoassay
Molecular Diagnosis
Others
Market segment by Application
Streptococcus
Clostridium Difficile
Candida
Tuberculosis
Others
Market segment by players, this report covers
QIAGEN
BD
bioMerieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.、
iemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe In Vitro Assays to Diagnose Infectious Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In Vitro Assays to Diagnose Infectious Diseases, with revenue, gross margin and global market share of In Vitro Assays to Diagnose Infectious Diseases from 2018 to 2023.
Chapter 3, the In Vitro Assays to Diagnose Infectious Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and In Vitro Assays to Diagnose Infectious Diseases market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of In Vitro Assays to Diagnose Infectious Diseases.
Chapter 13, to describe In Vitro Assays to Diagnose Infectious Diseases research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of In Vitro Assays to Diagnose Infectious Diseases
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of In Vitro Assays to Diagnose Infectious Diseases by Type
    • 1.3.1 Overview: Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global In Vitro Assays to Diagnose Infectious Diseases Consumption Value Market Share by Type in 2022
    • 1.3.3 Immunoassay
    • 1.3.4 Molecular Diagnosis
    • 1.3.5 Others
  • 1.4 Global In Vitro Assays to Diagnose Infectious Diseases Market by Application
    • 1.4.1 Overview: Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Streptococcus
    • 1.4.3 Clostridium Difficile
    • 1.4.4 Candida
    • 1.4.5 Tuberculosis
    • 1.4.6 Others
  • 1.5 Global In Vitro Assays to Diagnose Infectious Diseases Market Size & Forecast
  • 1.6 Global In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast by Region
    • 1.6.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region, (2018-2029)
    • 1.6.3 North America In Vitro Assays to Diagnose Infectious Diseases Market Size and Prospect (2018-2029)
    • 1.6.4 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size and Prospect (2018-2029)
    • 1.6.6 South America In Vitro Assays to Diagnose Infectious Diseases Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa In Vitro Assays to Diagnose Infectious Diseases Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 QIAGEN
    • 2.1.1 QIAGEN Details
    • 2.1.2 QIAGEN Major Business
    • 2.1.3 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.1.4 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 QIAGEN Recent Developments and Future Plans
  • 2.2 BD
    • 2.2.1 BD Details
    • 2.2.2 BD Major Business
    • 2.2.3 BD In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.2.4 BD In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 BD Recent Developments and Future Plans
  • 2.3 bioMerieux SA
    • 2.3.1 bioMerieux SA Details
    • 2.3.2 bioMerieux SA Major Business
    • 2.3.3 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.3.4 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 bioMerieux SA Recent Developments and Future Plans
  • 2.4 F. Hoffmann-La Roche, Ltd.
    • 2.4.1 F. Hoffmann-La Roche, Ltd. Details
    • 2.4.2 F. Hoffmann-La Roche, Ltd. Major Business
    • 2.4.3 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.4.4 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 F. Hoffmann-La Roche, Ltd. Recent Developments and Future Plans
  • 2.5 Hologic, Inc. (Gen-Probe)
    • 2.5.1 Hologic, Inc. (Gen-Probe) Details
    • 2.5.2 Hologic, Inc. (Gen-Probe) Major Business
    • 2.5.3 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.5.4 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Hologic, Inc. (Gen-Probe) Recent Developments and Future Plans
  • 2.6 Abbott
    • 2.6.1 Abbott Details
    • 2.6.2 Abbott Major Business
    • 2.6.3 Abbott In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.6.4 Abbott In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Abbott Recent Developments and Future Plans
  • 2.7 Quidel Corp.、
    • 2.7.1 Quidel Corp.、 Details
    • 2.7.2 Quidel Corp.、 Major Business
    • 2.7.3 Quidel Corp.、 In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.7.4 Quidel Corp.、 In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Quidel Corp.、 Recent Developments and Future Plans
  • 2.8 iemens Healthineers AG
    • 2.8.1 iemens Healthineers AG Details
    • 2.8.2 iemens Healthineers AG Major Business
    • 2.8.3 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.8.4 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 iemens Healthineers AG Recent Developments and Future Plans
  • 2.9 Bio-Rad Laboratories, Inc.
    • 2.9.1 Bio-Rad Laboratories, Inc. Details
    • 2.9.2 Bio-Rad Laboratories, Inc. Major Business
    • 2.9.3 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.9.4 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
  • 2.10 Danaher Corp.
    • 2.10.1 Danaher Corp. Details
    • 2.10.2 Danaher Corp. Major Business
    • 2.10.3 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.10.4 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Danaher Corp. Recent Developments and Future Plans
  • 2.11 OraSure Technologies, Inc
    • 2.11.1 OraSure Technologies, Inc Details
    • 2.11.2 OraSure Technologies, Inc Major Business
    • 2.11.3 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product and Solutions
    • 2.11.4 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 OraSure Technologies, Inc Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global In Vitro Assays to Diagnose Infectious Diseases Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of In Vitro Assays to Diagnose Infectious Diseases by Company Revenue
    • 3.2.2 Top 3 In Vitro Assays to Diagnose Infectious Diseases Players Market Share in 2022
    • 3.2.3 Top 6 In Vitro Assays to Diagnose Infectious Diseases Players Market Share in 2022
  • 3.3 In Vitro Assays to Diagnose Infectious Diseases Market: Overall Company Footprint Analysis
    • 3.3.1 In Vitro Assays to Diagnose Infectious Diseases Market: Region Footprint
    • 3.3.2 In Vitro Assays to Diagnose Infectious Diseases Market: Company Product Type Footprint
    • 3.3.3 In Vitro Assays to Diagnose Infectious Diseases Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global In Vitro Assays to Diagnose Infectious Diseases Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global In Vitro Assays to Diagnose Infectious Diseases Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Type (2018-2029)
  • 6.2 North America In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Application (2018-2029)
  • 6.3 North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country
    • 6.3.1 North America In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Country (2018-2029)
    • 6.3.2 United States In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 6.3.3 Canada In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Type (2018-2029)
  • 7.2 Europe In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Application (2018-2029)
  • 7.3 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country
    • 7.3.1 Europe In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Country (2018-2029)
    • 7.3.2 Germany In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 7.3.3 France In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 7.3.5 Russia In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 7.3.6 Italy In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region
    • 8.3.1 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Region (2018-2029)
    • 8.3.2 China In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 8.3.3 Japan In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 8.3.5 India In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 8.3.7 Australia In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Type (2018-2029)
  • 9.2 South America In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Application (2018-2029)
  • 9.3 South America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country
    • 9.3.1 South America In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country
    • 10.3.1 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)
    • 10.3.4 UAE In Vitro Assays to Diagnose Infectious Diseases Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 In Vitro Assays to Diagnose Infectious Diseases Market Drivers
  • 11.2 In Vitro Assays to Diagnose Infectious Diseases Market Restraints
  • 11.3 In Vitro Assays to Diagnose Infectious Diseases Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 In Vitro Assays to Diagnose Infectious Diseases Industry Chain
  • 12.2 In Vitro Assays to Diagnose Infectious Diseases Upstream Analysis
  • 12.3 In Vitro Assays to Diagnose Infectious Diseases Midstream Analysis
  • 12.4 In Vitro Assays to Diagnose Infectious Diseases Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on In Vitro Assays to Diagnose Infectious Diseases. Industry analysis & Market Report on In Vitro Assays to Diagnose Infectious Diseases is a syndicated market report, published as Global In Vitro Assays to Diagnose Infectious Diseases Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of In Vitro Assays to Diagnose Infectious Diseases market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,225.96
    		4,838.94
    		6,451.92
    		542,984.40
    		814,476.60
    		1,085,968.80
    		290,649.60
    		435,974.40
    		581,299.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo